Then, we performed western blots assay to detect the exosomal markers TSG101 and CD63, and the results revealed that both TSG101 and CD63 were highly enriched in exosomes derived from patients with esophageal cancer and healthy controls (Figure1D). Here, TSG101 is linked to esophageal cancer.